Sintilimab plus bevacizumab biosimilar IBI305 and chemotherapy in NSCLC

bryanphandhy Post time The day before yesterday 19:34 | Show all posts |Read mode
This post will be closed automatically in 2026-10-28 19:34
Reward15points

journalㄩThe Lancet Oncology

AuthorsㄩShun Lu; Lin Wu; Hong Jian; Ying Cheng; Qisen Guo

Published dateㄩ2022-9-

DOIㄩ10.1016/S1470-2045(22)00382-5

PDF linkㄩhttps://www.thelancet.com/pdfs/journals/lanonc/PIIS1470-2045(22)00382-5.pdf

Article linkㄩhttps://doi.org/10.1016/S1470-2045(22)00382-5

Article SourceㄩElsevier﹝

Remarkㄩ
Reply

Use magic Donate Report

All Reply0 Show all posts

Reply

You have to log in before you can reply Login | Register

Points Rules

Return to the list